For Your Kitchen
Cookbooks

Everyday recipes with room for flavor, variety, and real life. Dinner should not feel like homework.

Taste it

Sponsorship complete. Dine on...

Nutrition, wellness, weight loss, and calmer healthy living.

Comparative Safety of Imeglimin and Sitagliptin in Japanese Patients with Type 2 Diabetes

Oct 9, 2026
Comparative Safety of Imeglimin and Sitagliptin in Japanese Patients with Type 2 Diabetes

A recent pharmacy-based retrospective cohort study examined the comparative safety of imeglimin and sitagliptin, two oral antidiabetic medications, among Japanese patients with type 2 diabetes. Imeglimin, which enhances insulin secretion and improves insulin sensitivity, is a newer drug in the market, but comparative real-world safety data with widely used dipeptidyl peptidase-4 (DPP-4) inhibitors like sitagliptin have been limited. The study analyzed data from community pharmacies across Japan, focusing on new users of these medications from 2022 to 2024. It included 1,140 new imeglimin users and 990 new sitagliptin users, evaluating the incidence of adverse events such as gastrointestinal issues and hypoglycemia. The primary outcome was assessed using Cox proportional hazards models. The results indicated that 31% of imeglimin users reported at least one adverse event, compared to 22% of sitagliptin users. Notably, the risk of hypoglycemia was not significantly different between the two groups, with an adjusted hazard ratio of 0.66. However, imeglimin was associated with a significantly higher risk of gastrointestinal events, particularly nausea, diarrhea, and abdominal discomfort, with adjusted hazard ratios of 15.34, 7.90, and 6.02, respectively. Sensitivity analyses indicated that the risk of gastrointestinal symptoms was even more pronounced among patients receiving imeglimin as monotherapy. The findings suggest that while imeglimin is effective in managing blood glucose levels, clinicians should be vigilant about gastrointestinal side effects, especially in older patients with complex treatment regimens. This study underscores the need for careful monitoring during the initiation of imeglimin therapy to ensure patient safety and optimize treatment outcomes.

For Your Kitchen
Cookbooks
Taste it
Kitchen Scales
Taste it
Meal Prep Containers
Taste it

Sponsorship complete. Dine on...

For Your Kitchen
Cookbooks
Taste it
Kitchen Scales
Taste it
Meal Prep Containers
Taste it
Vegetable Prep & Salad Spinners
Taste it

Sponsorship complete. Dine on...

For Your Kitchen
Cookbooks

Everyday recipes with room for flavor, variety, and real life. Dinner should not feel like homework.

Taste it
Kitchen Scales

Kitchen scales for recipes that deserve more precision than 'that looks about right.'

Taste it
Meal Prep Containers

Give tomorrow's lunch a proper home. Containers for meals worth looking forward to.

Taste it
Vegetable Prep & Salad Spinners

Salad spinners and vegetable-prep tools for everyday salads, bowls, and side dishes. A little less kitchen setup, a little more time to enjoy the meal.

Taste it
Blenders & Smoothie Tools

Blenders for fruit, yogurt, soups, and the combinations you actually enjoy. Everyday kitchen tools, not a promise in a glass.

Taste it
Sheet Pans & Roasting Essentials

Sheet pans and roasting racks for vegetables and simple oven meals. Useful equipment for dinner without an elaborate production.

Taste it

Sponsorship complete. Dine on...

Across our publications

In Other News

Latest stories from other publications.

Explore all publications (opens in a new tab)